Cargando…
When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs
INTRODUCTION: New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resistance, blood pressure and body weight, in addition to avoiding inappropriate insulin therapy, resp...
Autores principales: | Volpe, Sara, Tortorella, Cosimo, Solfrizzi, Vincenzo, Piazzolla, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352573/ https://www.ncbi.nlm.nih.gov/pubmed/34385826 http://dx.doi.org/10.2147/DMSO.S321340 |
Ejemplares similares
-
Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
por: Piazzolla, Giuseppina, et al.
Publicado: (2022) -
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome
por: Piazzolla, Giuseppina, et al.
Publicado: (2019) -
Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study
por: Volpe, Sara, et al.
Publicado: (2022) -
Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D
por: Piazzolla, Giuseppina, et al.
Publicado: (2017) -
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
por: Tentolouris, Anastasios, et al.
Publicado: (2019)